TKR Insider Filing: Lucian Boldea Receives Time- and Performance-Based RSUs
Rhea-AI Filing Summary
Lucian Boldea, President and CEO and a director of The Timken Company (TKR), reported equity awards on 09/01/2025. The Form 4 discloses three restricted share unit (RSU) grants: 91,775 time-based RSUs that vest 33% on 09/01/2026, 33% on 09/01/2027 and 34% on 09/01/2028; 31,675 time-based RSUs that vest 25% per year beginning at grant; and 47,500 performance-based RSUs tied to performance between 01/01/2025 and 12/31/2027. Each grant has a $0 per-share exercise/conversion price and is reported as directly owned. The reported transactions were filed by one reporting person and signed on 09/02/2025.
Positive
- Grants combine time-based and performance-based RSUs, aligning retention and performance incentives
- Vesting schedules span multiple years, promoting long-term alignment with shareholders
- Disclosure filed timely (transaction 09/01/2025, Form signed 09/02/2025)
Negative
- No information on performance metrics for the 47,500 performance-based RSUs is provided in this filing
- Monetary value per award not provided beyond $0 conversion price typical for RSUs, so economic impact is not quantified
Insights
TL;DR: CEO received time-based and performance-based RSUs totaling 170,950 units with multi-year vesting and a multi-year performance period.
The grant structure mixes time-based vesting and a performance-based award, aligning executive incentives with multi-year company performance and retention. Time-based awards vest over two- to three-year schedules, while the 47,500 RSUs depend on performance from 01/01/2025 to 12/31/2027, indicating linkage to multi-year goals. All awards are reported as direct ownership with no exercise price, consistent with restricted share unit mechanics. For governance, the disclosure is routine and complies with Section 16 reporting.
TL;DR: Routine Section 16 filing showing CEO equity grants; no exercises or sales reported.
The Form 4 documents acquisitions (grant) rather than dispositions, with no cash exercise price reported, which is typical for RSUs. Transaction date is 09/01/2025 and the filing was signed 09/02/2025. The filing identifies Boldea as both President & CEO and a director, and the Form was filed by one reporting person. There are no indications of stock sales, option exercises, or other reportable dispositions in this filing.